The DOI matches its Crossref record; 54 of the 55 references it cites were found in a registry or an index.
Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2
Open accessAbstract
OBJECTIVE: To develop and validate version two of the QRISK cardiovascular disease risk algorithm (QRISK2) to provide accurate estimates of cardiovascular risk in patients from different ethnic groups in England and Wales and to compare its performance with the modified version of Framingham score recommended by the National Institute for Health and Clinical Excellence (NICE). DESIGN: Prospective open cohort study with routinely collected data from general practice, 1 January 1993 to 31 March 2008. SETTING: 531 practices in England and Wales contributing to the national QRESEARCH database. PARTICIPANTS: 2.3 million patients aged 35-74 (over 16 million person years) with 140,000 cardiovascular events. Overall population (derivation and validation cohorts) comprised 2.22 million people who were white or whose ethnic group was not recorded, 22,013 south Asian, 11,595 black African, 10,402 black Caribbean, and 19,792 from Chinese or other Asian or other ethnic groups. MAIN OUTCOME MEASURES: First (incident) diagnosis of cardiovascular disease (coronary heart disease, stroke, and transient ischaemic attack) recorded in general practice records or linked Office for National Statistics death certificates. Risk factors included self assigned ethnicity, age, sex, smoking status, systolic blood pressure, ratio of total serum cholesterol:high density lipoprotein cholesterol, body mass index, family history of coronary heart disease in first degree relative under 60 years, Townsend deprivation score, treated hypertension, type 2 diabetes, renal disease, atrial fibrillation, and rheumatoid arthritis. RESULTS: The validation statistics indicated that QRISK2 had improved discrimination and calibration compared with the modified Framingham score. The QRISK2 algorithm explained 43% of the variation in women and 38% in men compared with 39% and 35%, respectively, by the modified Framingham score. Of the 112,156 patients classified as high risk (that is, >or=20% risk over 10 years) by the modified Framingham score, 46,094 (41.1%) would be reclassified at low risk with QRISK2. The 10 year observed risk among these reclassified patients was 16.6% (95% confidence interval 16.1% to 17.0%)-that is, below the 20% treatment threshold. Of the 78 024 patients classified at high risk on QRISK2, 11,962 (15.3%) would be reclassified at low risk by the modified Framingham score. The 10 year observed risk among these patients was 23.3% (22.2% to 24.4%)-that is, above the 20% threshold. In the validation cohort, the annual incidence rate of cardiovascular events among those with a QRISK2 score of >or=20% was 30.6 per 1000 person years (29.8 to 31.5) for women and 32.5 per 1000 person years (31.9 to 33.1) for men. The corresponding figures for the modified Framingham equation were 25.7 per 1000 person years (25.0 to 26.3) for women and 26.4 (26.0 to 26.8) for men). At the 20% threshold, the population identified by QRISK2 was at higher risk of a CV event than the population identified by the Framingham score. CONCLUSIONS: Incorporating ethnicity, deprivation, and other clinical conditions into the QRISK2 algorithm for risk of cardiovascular disease improves the accuracy of identification of those at high risk in a nationally representative population. At the 20% threshold, QRISK2 is likely to be a more efficient and equitable tool for treatment decisions for the primary prevention of cardiovascular disease. As the validation was performed in a similar population to the population from which the algorithm was derived, it potentially has a "home advantage." Further validation in other populations is therefore advised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Many risk assessment systems are available and have been comprehensively reviewed, including different Framingham models, 41 Systemic Coronary Risk Estimation (SCORE), 42 ASSIGN (CV risk estimation model from the Scottish Intercollegiate Guidelines Network), 43 Q-Risk, 44 Prospective Cardiovascular Munster Study (PROCAM), 45 Reynolds, 46,47 CUORE, 48 the Pooled Cohort equations 49 and Globorisk. 5”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Missing data: our view of the state of the art
Schafer, J. L., & Graham, J. W. (2002) · Psychological Methods · doi:10.1037/1082-989x.7.2.147 · Cited by 11,638
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Multiple Imputation of Missing Values
Royston, P. (2004) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0400400301 · Cited by 2,340 · cited 1×
“We used fractional polynomials to model non-linear risk relations with continuous variables where appropriate.”
Cardiovascular disease risk profiles
Anderson, K. M., Odell, P. M., Wilson, P. W. F., & Kannel, W. B. (1991) · American Heart Journal · doi:10.1016/0002-8703(91)90861-b · Cited by 2,163
Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
Probability of stroke: a risk profile from the Framingham Study.
Wolf, P. A., D'Agostino, R. B., Belanger, A. J., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.3.312 · Cited by 1,782
McKeigue, P. M., Shah, B., & Marmot, M. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)91164-p · Cited by 1,618
Research works printed but not linked: 3
- Gail M, Pfeiffer R. On evaluating models of absolute risk. Biostatistics 2005;6:227-39.
- Erika Graf CSWSMS. Assessment and comparison of prognostic classification schemes for survival data. Stat Med 1999;18:2529-45.
- Maradit-Kremers H, Crowson C, Nicola P, Ballman K, Roger V, Jacobsend S, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005;52:402-11.
Cited by
Sorted by citations
Items 801–900 of 1,000
Delles, C., & Jardine, A. G. (2010) · Diabetologia · doi:10.1007/s00125-010-1942-2 · Cited by 11
Hippisley‐Cox, J., Clift, A. K., Coupland, C. A. C., Keogh, R. H., Diaz‐Ordaz, K., Williamson, E., Harrison, E. M., Hayward, A. C., Hemingway, H., Horby, P., et al. (2020) · medRxiv · doi:10.1101/2020.06.28.20141986 · Cited by 10
“Protocol for the development and evaluation of a tool for predicting risk of short-term adverse outcomes due to COVID-19 in the general UK population Julia Hippisley-Cox [1], Ash K. Clift [1], Carol Coupland [2], Ruth Keogh [3], Karla Diaz-Ordaz [3], Elizabeth Williamson [3], Ewen M. Harrison [4], Andrew Hayward [5],…”
BackgroundSelf-citationBates, S. E., Thomas, C., Islam, N., Ahern, A. L., Breeze, P. R., Griffin, S. J., & Brennan, A. (2022) · BMC Public Health · doi:10.1186/s12889-022-12737-5 · Cited by 10
“It contributes to the risk of the first cardiovascular events as part of the QRISK2 prediction model [19].”
BackgroundJeffery, A., Bhanu, C., Walters, K. R., Wong, I. C. K., Osborn, D., & Hayes, J. (2022) · British Journal of General Practice · doi:10.3399/bjgp.2022.0295 · Cited by 10
Atzeni, F., Maiani, S., Corda, M., & Rodríguez‐Carrio, J. (2023) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2023.2170351 · Cited by 10
“The modification of the initial QRISK1 model to include RA was described to provide a better discrimination at the population level compared with that of the Framingham Risk Score [35].”
MethodBen‐Shabat, N., Gendelman, O., Fisher, L., Shani, U., Patt, Y. S., Watad, ., Skuja, V., McGonagle, D. G., & Amital, H. (2023) · Lara D. Veeken · doi:10.1093/rheumatology/kead153 · Cited by 10
Using Repeated Measurements to Predict Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
Gokhale, K. M., Chandan, J. S., Sainsbury, C. A. R., Peter Tiňo, B., Tahrani, A. A., Toulis, K. A., & Nirantharakumar, K. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.10.008 · Cited by 10
“After calculating the NRI the difference is negligible ( (cid:1) 1), with some indication that the QRISK is mildly better at assigning patients to the correct risk categories.”
MethodInfluentialLipids and Lipoproteins in Risk Prediction
Hadjiphilippou, S., & Ray, K. K. (2018) · Cardiology Clinics · doi:10.1016/j.ccl.2017.12.002 · Cited by 10
Arcani, R., Grapperon, A., Venton, G., Suchon, P., Verschueren, A., Bas, J., Salort‐Campana, E., Attarian, S., & Delmont, É. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2020.04.029 · Cited by 10
Gaio, V., Rodrigues, A. P., Kislaya, I., Barreto, M., Namorado, S., & Dias, C. M. (2020) · Acta Médica Portuguesa · doi:10.20344/amp.13009 · Cited by 10
“Recebido: 24 de outubro de 2019- Aceite: 29 de janeiro de 2020 | Copyright © Ordem dos Médicos 2020 Vânia GAIO1,2, Ana Paula RODRIGUES1, Irina KISLAYA1,2, Marta BARRETO1,2, Sónia NAMORADO1, Carlos Matias DIAS1,2 Acta Med Port 2020 Nov;33(11):726-732 ▪ https://doi.”
BackgroundHuang, Y. Y., Tian, W. B., Jiang, C. Q., Zhang, W. S., Zhu, F., Jin, Y. L., Lam, T. H., Xu, L., & Cheng, K. K. (2021) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-021-10163-3 · Cited by 10
Physical Activity, Sedentary Time, and Cardiometabolic Health in Heavy Goods Vehicle Drivers
Ruettger, K. B., Varela-Mato, V., Chen, Y., Edwardson, C. L., Guest, A. J., Gilson, N. D., Gray, L. J., Paine, N. J., Sherry, A. P., Sayyah, M., et al. (2022) · Journal of Occupational and Environmental Medicine · doi:10.1097/jom.0000000000002484 · Cited by 10
“The ten-year risk of having a cardiovascular event was calculated using the QRISK2 calculator.(23)”
MethodLaunders, N., Hayes, J., Price, G., Marston, L., & Osborn, D. (2022) · Psychological Medicine · doi:10.1017/s0033291722002811 · Cited by 9
“This approach is in line with previous research using primary care data, which suggests that more than 93% of individuals without ethnicity recorded are from a white ethnic group (Hippisley-Cox et al., 2008).”
Koshiaris, C., Archer, L., Lay-Flurrie, S. L., Snell, K. I. E., Riley, R. D., Stevens, R., Banerjee, A., Usher‐Smith, J. A., Clegg, A. P., Payne, R., et al. (2023) · British Journal of General Practice · doi:10.3399/bjgp.2022.0389 · Cited by 10
“Antihypertensive medications ACE Inhibitors 219 514 (12) 478 763 (13) Angiotensin II receptor blockers 59 077 (3) 136 917 (4) Alpha-blockers 34 335 (2) 68 129 (2) Beta-blockers 216 124 (12) 461 318 (12) Calcium channel blockers 193 142 (11) 426 141 (11) Thiazide and thiazide-like diuretics 180 071 (10) 397 971 (10) Ot…”
Data-driven scientific research based on public statistics: a bibliometric perspective
Velasco-López, J.-E., Carrasco, R. A., Cobo, M. J., & Fernández‐Avilés, G. (2023) · El Profesional de la Informacion · doi:10.3145/epi.2023.may.14 · Cited by 10
Drapkina, O. M., Shalnova, S. A., Васильевна, К. А., Kutsenko, V. A., Владимировна, К. А., Balanova, Y. А., Евстифеева, С. Е., Иванова, А. А., Имаева, А. Э., Владимирович, М. Н., et al. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3548 · Cited by 10
Chung, R., Xu, Z., Arnold, M., Ip, S., Harrison, H., Barrett, J., Pennells, L. A. M., Kim, L. G., Angelantonio, E. D., Paige, E., et al. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.122.029296 · Cited by 10
Adverse skeletal effects of drugs – beyond Glucocorticoids
O’Sullivan, S., & Grey, A. B. (2014) · Clinical Endocrinology · doi:10.1111/cen.12549 · Cited by 9
“[2,3] Clinicians should be aware that fracture risk can also be estimated using the FRAX or Garvan tools without BMD data.”
MethodNew Risk Markers for Cardiovascular Prevention
Backer, G. D. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0427-z · Cited by 11
Should doctors record their patients’ income?
Moscrop, A., & MacPherson, P. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x682009 · Cited by 10
Air pollution: the new cardiovascular risk factor
Langrish, J. P., Mills, N. L., & Newby, D. E. (2008) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2008.01850.x · Cited by 9
Stradling, C., Thomas, G. N., Hemming, K., Frost, G. S., García‐Pérez, I., Redwood, S., & Taheri, S. (2016) · BMJ Open · doi:10.1136/bmjopen-2015-010821 · Cited by 10
“alcohol intake and CV risk factors, to enable calculation of QRISK 10-year CV risk.(51) Blood pressure will be measured seated, with automated sphygmomanometer”
MethodComparison of application of different methods to estimate lifetime cardiovascular risk
Brotons, C., Calvo‐Bonacho, E., Moral, I., Puig‐Asensio, M., García‐Margallo, M. T., Cortés-Arcas, M. V., Catalina-Romero, C., Quevedo-Aguado, L., & Ruilope, L. M. (2015) · European Journal of Preventive Cardiology · doi:10.1177/2047487315579616 · Cited by 10
Liu, L., Tang, Z., Li, X., Luo, Y., Guo, J. C., Li, H., Liu, X., Tao, L., Wang, W., Yan, A., et al. (2016) · Medicine · doi:10.1097/md.0000000000002997 · Cited by 10
“QRISK2 CVD risk algorithm included ethnicity, age, sex, smoking status, SBP, HDL-C, BMI, and so on, which has improved the precision for identifying those with a high risk in a nationally representative population.(45) The finding of external validation for QRISK2 CVD risk score indicated that QRISK2 was more accurate…”
BackgroundInterventions to Reduce Ethnic and Racial Disparities in Dyslipidemia Management
Chang, A. Y., Abou-Arraj, N. E., & Rodriguez, F. (2019) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-019-0725-4 · Cited by 12
Cheng, I. T., Wong, K. T., Li, E. K., Wong, P. C. H., Lai, B. T. L., Yim, I. C., Ying, S. K. Y., Kwok, K. Y., Li, M., Li, T. K., et al. (2020) · RMD Open · doi:10.1136/rmdopen-2020-001364 · Cited by 10
Koo, S., Sharp, L., Hull, M. A., Rushton, S., Neilson, L. J., The OSCAR study team, McPherson, S., & Rees, C. J. (2021) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2021-000638 · Cited by 10
“All authors had access to the study data and reviewed and approved the final manuscript.”
French, C., Cubbidge, R. P., & Heitmar, R. (2022) · Ophthalmic and Physiological Optics · doi:10.1111/opo.12967 · Cited by 10
Zhang, L., Niu, M., Zhang, H., Wang, Y., Zhang, H., Mao, Z., Zhang, X., He, M., Wu, T., Wang, Z., et al. (2022) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2022.104746 · Cited by 10
Marsh, R. W. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9634-x · Cited by 10
Cardiovascular risk score in Rheumatoid Arthritis
Wagan, A. A., Mahmud, T.-E.-H., Rasheed, A., Zafar, Z. A., Rehman, A. U., & Ali, A. (2016) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.323.9779 · Cited by 10
Cholesterol and prevention of atherosclerotic events: limits of a new frontier
de Macedo, L. E. T., & Faerstein, E. (2017) · Revista de Saúde Pública · doi:10.1590/s1518-8787.2017051006416 · Cited by 10
Cardiovascular risk prediction based on Retinal Vessel Analysis using machine learning
Fathalla, K. M., Ekárt, A., Seshadri, S., & Gherghel, D. (2016) · Conference proceedings/Conference proceedings - IEEE International Conference on Systems, Man, and Cybernetics · doi:10.1109/smc.2016.7844352 · Cited by 10
FASim: A 3D Serious Game for the First Aid Emergency
Benkhedda, S., & Bendella, F. (2019) · Simulation & Gaming · doi:10.1177/1046878119865913 · Cited by 10
“arrest having as entry variables referred to in (Hippisley-Cox et al., 2008).”
BackgroundMethodInfluentialFidelity of the delivery of NHS Health Checks in general practice: an observational study
Paxton, B., Mills, K., & Usher‐Smith, J. A. (2020) · BJGP Open · doi:10.3399/bjgpopen20x101077 · Cited by 10
Obstructive sleep apnoea: quantifying its association with obesity and snoring
Parekh, R., Green, E., & Majeed, A. (2012) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2012.00091 · Cited by 10
Ethnic minorities and their perceptions of the quality of primary care
Sheikh, A. (2009) · BMJ · doi:10.1136/bmj.b3797 · Cited by 10
Self-citationRisk scoring for the primary prevention of cardiovascular disease
Karmali, K. N., Persell, S. D., Lloyd‐Jones, D. M., Perel, P., & Huffman, M. D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006887.pub3 · Cited by 12
Agyekum, F., Akumiah, F. K., Nguah, S. B., Appiah, L. T., Ganatra, K., Adu‐Boakye, Y., Folson, A. A., Ayetey, H., & Owusu, I. K. (2024) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2024.100670 · Cited by 9
“…commonly used across the globe are the Framingham risk score (FRS) [6], the pooled cohort equation (PCE) [7], the SCORE [8], the Reynold ’ s Risk Score [9], the QRISK 2 [10], JBS3 [11], and the World Health Organization/International Society of Hypertension (WHO/ISH) risk prediction charts [12].”
MethodMcFadden, J., Matthews, J. C., Scott, L., Herholz, K., Dickie, B., Haroon, H. A., Sparasci, O., Ahmed, S., Kyrtata, N., Parker, G. J. M., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103746 · Cited by 9
Yu, L., Wu, J.-C., Wu, X., Chen, C., Chen, Y., Fang, L., & Zheng, D. (2025) · BMC Public Health · doi:10.1186/s12889-025-24921-4 · Cited by 14
Martínez-Millana, A., Fernández-Llatas, C., Sacchi, L., Segagni, D., Guillen, S. G., Bellazzi, R., & Traver, V. (2015) · Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC) · doi:10.1109/embc.2015.7320288 · Cited by 9
Studziński, K., Tomasik, T., Krzysztoń, J., Jozwiak, J. J., & Windak, A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014206 · Cited by 9
Increasing uptake of NHS Health Checks: a randomised controlled trial using GP computer prompts
Gold, N., Tan, K. L. L., Sherlock, J., Watson, R. L., & Chadborn, T. (2021) · British Journal of General Practice · doi:10.3399/bjgp.2020.0887 · Cited by 9
“24 This evidence highlights the potential role of primary care to deliver preventive interventions, which can also save money in the long term.”
BackgroundChang, C., Cheng, W., Ma, W., Chen, P., Chen, C., Shen, P.-C., Chen, C.-C., Chang, S., Lai, Y., & Chen, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111419 · Cited by 9
“org assessed on 22 February 2021) [49].”
Aminuddin, N., Achuthan, A., Ruhaiyem, N. I. R., Nassir, C. M. N. C. M., Idris, N. S., & Mustapha, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-15710-9 · Cited by 10
Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study
Strongman, H., Herrett, E. L., Jackson, R., Sweeting, M. J., Lyon, A. R., Stanway, S. J., Lawson, C. A., Kadam, U. T., Smeeth, L. L., & Bhaskaran, K. (2022) · British Journal of General Practice · doi:10.3399/bjgp.2022.0088 · Cited by 9
D’Urso, S., & Hwang, L. (2023) · Nutrients · doi:10.3390/nu15224815 · Cited by 10
Modelling the effects of the exposome score within the extended psychosis phenotype.
Rejek, M., & Misiak, B. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.11.022 · Cited by 9
Laitinen, D. L., & Manthena, S. R. (2010) · Advances in Therapy · doi:10.1007/s12325-010-0019-4 · Cited by 9
Marshall, T. P. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2009.114 · Cited by 10
Brunner, E. J., Shipley, M. J., Marmot, M. G., Mika Kivimaki, B., & Witte, D. R. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02921.x · Cited by 9
Cardiovascular risk and prevention in diabetes mellitus
Roberts, A. W. (2010) · Clinical Medicine · doi:10.7861/clinmedicine.10-5-495 · Cited by 9
Salisbury, C., O’Cathain, A., Thomas, C., Edwards, L., Montgomery, A. A., Hollinghurst, S. P., Large, S., Nicholl, J. P., Pope, C. J., Rogers, A. E., et al. (2017) · Programme Grants for Applied Research · doi:10.3310/pgfar05010 · Cited by 9
“One further explanation for the limited benefit in terms of QRISK2 score is the effect of smoking, which makes a major contribution to overall CVD risk.(195) In this trial we observed a non-significant trend towards a greater chance of being a smoker in the intervention group than in the usual care group after 12 mont…”
BackgroundVlismas, K., Panagiotakos, D. B., Pitsavos, C. S., Chrysohoou, C. A., Skoumas, Y., Stavrinos, V., & Stefanadis, C. (2011) · PubMed · Cited by 9
Is the Population Detected by Screening in China Truly at High Risk of Stroke?
Wang, Y., Wang, J., Cheng, J., Liang, X., Li, X., & Lu, W. (2018) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2018.03.009 · Cited by 9
How Low to Go With Lipid-Lowering Therapies in a Cost-effective and Prudent Manner
Cardoso, R. N., Blumenthal, R. S., Kopecky, S. L., López-Jiménez, F. A., & Martin, S. S. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.08.011 · Cited by 10
Anagnostou, A., Taylor, S. J. E., Groen, D., Suleimenova, D., Anokye, N., Bruno, R., & Barbera, R. (2019) · Winter Simulation Conference · doi:10.1109/wsc40007.2019.9004845 · Cited by 9
“2008) and Type 2 Diabetes (QDiabetes) (Hippisley-Cox et al. 2017) risks. Incidence data from literature is used to estimate the probabilities of depression and MSI (Rait et al. 2009; Wijlaars et al. 2012). The above, however, do not factor in the physical activity level of an individual and its effect on health condit…”
MethodRastrelli, G., Yannas, D., Mucci, B., Corona, G., & Maggi, M. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.08.012 · Cited by 9
Chen, Y., Chen, P., Chang, C., Lin, C., Chen, H., Lan, J., Chang, S., & Chen, D. (2020) · Life · doi:10.3390/life10120330 · Cited by 9
“The global 10-year risk for a heart attack or stroke was estimated by calculating the QRISK-2 scores [29,30].”
MethodPanjiyar, B. K., Davydov, G., Nashat, H., Ghali, S., Afifi, S., Suryadevara, V., Habab, Y., Hutcheson, A., & Franchini, A. P. A. (2023) · Cureus · doi:10.7759/cureus.43003 · Cited by 10
Davey, R., Cochrane, T., Iqbal, Z., Rajaratnam, G., Chambers, R. M., Mawby, Y., Picariello, L., Leese, C., & Ryder, N. (2010) · Contemporary Clinical Trials · doi:10.1016/j.cct.2010.04.002 · Cited by 9
Vikhireva, O., Broda, G., Kubínová, R., Malyutina, S. K., Pająk, A., Tamošiūnas, A., Škodová, Z., Симонова, Г. И., Bobák, M., & Pikhart, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094344 · Cited by 9
Are Population-Based Diabetes Models Useful for Individual Risk Estimation?
Saver, B. G., Hargraves, J. L., & Mazor, K. M. (2011) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2011.04.110029 · Cited by 9
Gujral, D. M., Shah, B. N., Chahal, N., Bhattacharyya, S., Senior, R., Harrington, K. J., & Nutting, C. (2015) · QJM · doi:10.1093/qjmed/hcv120 · Cited by 9
Scores de risco cardiovascular: utilidade e limitações
Rocha, E. (2016) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2015.11.002 · Cited by 11
Clark, C. E., Boddy, K., Warren, F. C., Taylor, R. S., Aboyans, V., Cloutier, L., McManus, R. J., Shore, A. C., & Campbell, J. L. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-016844 · Cited by 9
Nishimoto, M., Tagawa, M., Matsui, M., Eriguchi, M., Samejima, K., Iseki, K., Iseki, C., Asahi, K., Yamagata, K., Konta, T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49003-5 · Cited by 9
Cardiovascular risk prediction tools made relevant for GPs and patients
de Vries, T. I., & Visseren, F. L. J. (2020) · Heart · doi:10.1136/heartjnl-2019-316377 · Cited by 9
Shalnova, S. A., Drapkina, O. M., Васильевна, К. А., Yarovaya, E. B., Kutsenko, V. A., Metelskaya, V. A., Владимировна, К. А., Balanova, Y. А., Litinskaya, O. A., & Pokrovskaya, M. S. (2021) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2021-2980 · Cited by 9
Ekundayo, O. J., Vassar, S. D., Williams, L. S., Bravata, D. M., & Cheng, E. M. (2011) · Stroke · doi:10.1161/strokeaha.110.603340 · Cited by 9
Vascular risk screening: possible or too much, too soon?
Wierzbicki, A. S., & Reynolds, T. (2009) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2009.02111.x · Cited by 9
Academic primary care: at a tipping point?
Hobbs, R. F., & Taylor, C. J. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x679543 · Cited by 9
Symptoms and risk factors to identify people with suspected cancer in primary care
Hippisley‐Cox, J., & Coupland, C. A. C. (2013) · British Journal of General Practice · doi:10.3399/bjgp13x664135 · Cited by 9
Self-citationChimakurthi, C. R., & Rowe, I. A. C. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.034 · Cited by 9
Andreotti, F., Heldt, F. S., Abu‐Jamous, B., Li, M., Javer, A., Carr, O., Jovanović, S., Lipunova, N., Irving, B., Khan, R. T., et al. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.08491 · Cited by 9
“r the task of predicting CVD events from a sequence of n days containing hospital observations, the following approaches are evaluated. 2.2.1. BASELINE CLINICAL APPROACH The QRISK2 (QRISK) algorithm (Hippisley-Cox et al., 2008) is the UK primary care standard clinical assessment tool, which calculates 10-year risk of…”
InfluentialThe Economics of Walking About and Predicting UnemploymentPreprint
Blanchflower, D. G., & Bryson, A. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3909603 · Cited by 9
Communicating cardiovascular risk: Systematic review of qualitative evidence
Lorenc, T., Stokes, G., Fulbright, H., Sutcliffe, K., & Sowden, A. J. (2024) · Patient Education and Counseling · doi:10.1016/j.pec.2024.108231 · Cited by 8
Patients who discontinued statin treatment: a protocol for cohort study using primary care data
Vinogradova, Y., Coupland, C. A. C., Brindle, P. M., & Hippisley‐Cox, J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008701 · Cited by 8
Self-citationVermunt, J. V., Kennedy, S., & Garovic, V. D. (2020) · Current Hypertension Reports · doi:10.1007/s11906-019-1014-z · Cited by 8
Factors predicting statin prescribing for primary prevention: a historical cohort study
Finnikin, S., Willis, B. H., Ryan, R. P., Evans, T., & Marshall, T. P. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x714065 · Cited by 8
Moons, K. G. M., Altman, D. G., Reitsma, J. B., loannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, P. G. S. (2022) · Digital Diagnostics · doi:10.17816/dd110794 · Cited by 10
Bergström, G. M. L., Hagberg, E., Björnson, E., Adiels, M., Bonander, C., Strömberg, U., Andersson, J. S. O., Brunström, M., Carlhäll, C., Engström, G., et al. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034603 · Cited by 7
“Family history of myocardial infarction is included in some, 30,31 but not all, 1 of the previous clinical risk algorithms.”
Wolpe, N., Perrottelli, A., Giuliani, L., Yang, Z., Rekhi, G., Jones, P. B., Bernardo, M., García‐Portilla, M. P., Kaiser, S., Robert, G., et al. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.12.016 · Cited by 8
Nweke, M., Oyirinnaya, P., Nwoha, P. U., Mitha, S. B., Mshunqane, N., Govender, N., Ukwuoma, M., & Ibeneme, S. C. (2025) · BMC Neurology · doi:10.1186/s12883-025-04229-x · Cited by 9
“T h e i m p l i c a t i o n o f t h e c r i t i c i s m v e r s u s o u r fi n d i n g s Q R I S K [ 65 ] A g e , s e x , s m o k i n g , s y s t o l i c b l o o d p r e ss u r e , t h e r a t i o o f t o t a l s e r u m c h o l e s t e r o l t o H D L , B M I , f a m i l y h i s t o r y o f c o r…”
InfluentialCardiovascular disease risk score prediction models for women and its applicability to Asians
Dhaliwal, S. S., Goh, L. G. H., Welborn, T. A., Thompson, P. L., Maycock, B. R., Kerr, D. A., Lee, A. H., Bertolatti, D., Clark, K., Naheed, R., et al. (2014) · International Journal of Women s Health · doi:10.2147/ijwh.s55225 · Cited by 8
Thompson, A., Guthrie, B., & Payne, K. (2017) · Medical Decision Making · doi:10.1177/0272989x17700846 · Cited by 8
Wan, E. Y. F., Yu, E. Y. T., Chin, W. Y., Fung, C. S. C., Kwok, R. L. P., Chao, D. V. K., Chan, K. H., Hui, E. M., Tsui, W. W. S., Tan, K. C. B., et al. (2018) · BMJ Open · doi:10.1136/bmjopen-2018-023070 · Cited by 8
Mortality prediction enhancement in end-stage renal disease: A machine learning approach
Macias, E., Morell, A., Serrano, J., Vicario, J. L., & Ibeas, J. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100351 · Cited by 8
Biomarkers in essential hypertension
Pattanaik, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815923-1.00008-0 · Cited by 10
Hider, S., Bucknall, M., Jinks, C., Cooke, K., Cooke, K., Desilva, E. E., Finney, A. G., Healey, E. L., Herron, D., Machin, A. R., et al. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-020-00750-7 · Cited by 7
Miao, S., Chen, P., Li, D., Shen, S., & Wen, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-052568 · Cited by 8
Johnston, I. S., Miles, B., Soós, B., Garies, S., Perez, G., Queenan, J. A., Drummond, N., & Singer, A. G. (2022) · BMC Family Practice · doi:10.1186/s12875-022-01735-6 · Cited by 8
“The importance of SES to CVD risk, including pharmacotherapy management, has been described in other countries such as the United Kingdom, [7, 8] but is not well studied in a Canadian primary care context.”
BackgroundSheikh, K., Sayeed, S., Asif, A., Siddiqui, M. F., Rafeeq, M. M., Sahu, A., & Ahmad, S. (2022) · Studies in computational intelligence · doi:10.1007/978-981-19-6379-7_13 · Cited by 8
Mizani, M. A., Dashtban, A., Pasea, L., Lai, A. G., Thygesen, J. H., Tomlinson, C., Handy, Á., Mamza, J. B., Morris, T., Khalid, S., et al. (2022) · Journal of the Royal Society of Medicine · doi:10.1177/01410768221131897 · Cited by 8
Múñoz, Ó., Peña, Á. A. G., Fernández-Ávila, D. G., Higuera, A. M., Ruiz, Á. J., Aschner, P. J., Toro, J. M., Arteaga, J. M., Merchán, A., Sánchez, G., et al. (2015) · Revista Colombiana de Cardiología · doi:10.1016/j.rccar.2015.04.009 · Cited by 12
Begh, R. A., Aveyard, P. N., Upton, P., Bhopal, R. S., White, M. J., Amos, A., Prescott, R. J., Bedi, R., Barton, P. M., Fletcher, M. J., et al. (2009) · Trials · doi:10.1186/1745-6215-10-71 · Cited by 8
Self-citationDalton, A., Bottle, A., Soljak, M., Okoro, C., Majeed, A., & Millett, C. J. (2011) · Journal of Innovation in Health Informatics · doi:10.14236/jhi.v19i4.817 · Cited by 8
Natural History of Treated and Untreated Hypertension
Volpe, M., & Savoia, C. (2018) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-319-59918-2_4 · Cited by 8
Jargalsaikhan, B., Saqlain, M., Sherazi, S. W. A., Jae, M. H., Kang, I. U., Ali, S., & Lee, J. Y. (2019) · Smart innovation, systems and technologies · doi:10.1007/978-981-13-9714-1_28 · Cited by 8
Metadata
- Authors
- Hippisley-Cox, J., Coupland, C., Vinogradova, Y., Robson, J., Minhas, R., Sheikh, A., & Brindle, P.
- Affiliations
- University of Nottingham (GB)
- Queen Mary University of London (GB)
- Medway NHS Foundation Trust (GB)
- University of Edinburgh (GB)
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2008-06-23
- Volume
- 336
- Issue
- 7659
- Pages
- 1475-1482
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- PMC
- PMC2440904
- OpenAlex
- W2055838663
- Cited by
- 1,459
- References
- 55
- Citations by year
- 2026: 25 · 2025: 49 · 2024: 58 · 2023: 86 · 2022: 100 · 2021: 108 · 2020: 108 · 2019: 106 · 2018: 94 · 2017: 102 · 2016: 101 · 2015: 95 · 2014: 90 · 2013: 64 · 2012: 80
- FWCI
- 62.43
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- BMJ (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
- Funders
- University of Nottingham
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- QRISK2, cardiovascular risk prediction, risk reclassification, coronary artery disease, stroke, transient ischemic attack, ethnic groups, South Asian patients, risk discrimination and calibration, cardiovascular disease prevention, NICE guidelines, QResearch database, England and Wales, general practice records, family history of coronary heart disease
- MeSH terms
- Adult, Aged, Algorithms, Cardiovascular Diseases, England, Female, Humans, Male, Middle Aged, Prognosis, Wales, Epidemiologic Studies, Age Distribution, Sex Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review